Sai Life Sciences Ltd announced plans to recruit over 700 professionals in FY27 at its Hyderabad R&D campus. The hiring drive will span scientific, technical, and management roles, supporting global demand for end-to-end drug discovery, development, and manufacturing services. The expansion strengthens India’s position in the CRDMO sector.
Sai Life Sciences Ltd, one of India’s leading integrated contract research, development, and manufacturing organizations (CRDMOs), has unveiled a major recruitment initiative for FY27. The company will hire more than 700 professionals across scientific, technical, and managerial domains to scale its capabilities in response to rising global demand for drug discovery and development services.
Key Highlights
-
Sai Life Sciences to recruit 700+ professionals during FY27
-
Hiring will cover roles in medicinal chemistry, biology, DMPK, process and analytical development, formulation, and management
-
Recruitment drive focused on strengthening operations at the Hyderabad integrated R&D campus
-
Expansion aligns with growing global demand for end-to-end CRDMO services
-
Move reinforces India’s role in global pharmaceutical innovation and manufacturing
Strategic Impact
The recruitment initiative reflects Sai Life Sciences’ commitment to expanding its workforce and infrastructure to meet international standards. By scaling operations, the company aims to enhance its ability to deliver comprehensive solutions across the drug development lifecycle. This expansion also positions Hyderabad as a key hub for pharmaceutical R&D and manufacturing excellence.
With a strong focus on innovation, compliance, and global partnerships, Sai Life Sciences continues to strengthen its footprint in the life sciences sector, contributing to India’s growing reputation as a global pharmaceutical powerhouse.
Sources: Business Wire, Morningstar News, Economic Times